Active Ingredient(s): Canakinumab
FDA Approved: * June 17, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Anti-Inflammatory

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ilaris Overview

Canakinumab (INN, trade name Ilaris, previously ACZ885)[2] is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.[3] Canakinumab was approved for the treatment of cryopyrin-associated periodic syndromes (CAPS) by the U.S. Food and Drug Administration (FDA) in June 2009[4] and by the European Medicines Agency in October 2009.[...

Read more Ilaris Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Ilaris Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 180mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ilaris: (2 results)

Sorted by National Drug Code
  • 0078-0582 Ilaris 150 mg/ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
  • 0078-0734 Ilaris 150 mg/ml Subcutaneous Injection, Solution by Novartis Pharmaceuticals Corporation

Other drugs which contain Canakinumab or a similar ingredient: (1 result)

Related Ilaris Topics:

How old is this product...
le cout d Ilaris
je dois commencer ce med. mais il est trop cher . comment faire ? je soufre bcq. j ai de la fievre familliale qui me cau...
how good is the new medicine Ilaris
Its is the recent new of the product Ilaris has got a US FDA approval and has been there across various territories. Doe...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 May 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA